[Transfusion policy toward a patient with an anti-Cartwright antibody (anti-Yta)]. / Actitud transfusional frente a un paciente con un anticuerpo anti-Cartwright (anti-Yta).

ABSTRACT

We have observed one patient with hepatic cirrhosis showing on her antibody screening an anti-Yta. We studied the 51 Cr-labelled erythrocyte survival using either Yt (a+) and autologous blood red cells. She was transfused two Yt (a+) red blood cell concentrates without any adverse reaction.